130 related articles for article (PubMed ID: 8867695)
1. Proliferative potential and malignant transformation of ganglioglioma: immunohistochemical studies by MIB-1 and p53 staining.
Nagai M; Tejima T; Arai T; Narita J; Watanabe K; Ochiai C; Yoshimoto Y; Endoh M
Noshuyo Byori; 1995; 12(2):141-9. PubMed ID: 8867695
[TBL] [Abstract][Full Text] [Related]
2. Desmoplastic infantile ganglioglioma--clinicopathological and immunohistochemical study of four cases.
Rout P; Santosh V; Mahadevan A; Kolluri VR; Yasha TC; Shankar SK
Childs Nerv Syst; 2002 Oct; 18(9-10):463-7. PubMed ID: 12382166
[TBL] [Abstract][Full Text] [Related]
3. Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype.
Rushing EJ; Brown DF; Hladik CL; Risser RC; Mickey BE; White CL
Mod Pathol; 1998 May; 11(5):464-70. PubMed ID: 9619600
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical examination of proliferative potentials and the expression of cell cycle-related proteins of intracranial chordomas.
Matsuno A; Sasaki T; Nagashima T; Matsuura R; Tanaka H; Hirakawa M; Murakami M; Kirino T
Hum Pathol; 1997 Jun; 28(6):714-9. PubMed ID: 9191006
[TBL] [Abstract][Full Text] [Related]
5. Bcl-2 and Bcl-X expression in gangliogliomas.
Prayson RA
Hum Pathol; 1999 Jun; 30(6):701-5. PubMed ID: 10374780
[TBL] [Abstract][Full Text] [Related]
6. Aberrant TP53 protein accumulation in the neuronal component of ganglioglioma.
Fukushima T; Katayama Y; Watanabe T; Yoshino A; Komine C; Yokoyama T
J Neurooncol; 2005 Apr; 72(2):103-6. PubMed ID: 15925988
[TBL] [Abstract][Full Text] [Related]
7. Desmoplastic infantile ganglioglioma. Morphological, immunohistochemical and genetic features.
Cerdá-Nicolás M; Lopez-Gines C; Gil-Benso R; Donat J; Fernandez-Delgado R; Pellin A; Lopez-Guerrero JA; Roldan P; Barbera J
Histopathology; 2006 Apr; 48(5):617-21. PubMed ID: 16623795
[No Abstract] [Full Text] [Related]
8. The proliferative potential of the pilocytic astrocytoma: the relation between MIB-1 labeling and clinical and neuro-radiological follow-up.
Dirven CM; Koudstaal J; Mooij JJ; Molenaar WM
J Neurooncol; 1998 Mar; 37(1):9-16. PubMed ID: 9525833
[TBL] [Abstract][Full Text] [Related]
9. Recurrent anaplastic ganglioglioma: pathological characterization of tumor cells. Case report.
Sasaki A; Hirato J; Nakazato Y; Tamura M; Kadowaki H
J Neurosurg; 1996 Jun; 84(6):1055-9. PubMed ID: 8847572
[TBL] [Abstract][Full Text] [Related]
10. Anaplastic pleomorphic xanthoastrocytoma.
Prayson RA; Morris HH
Arch Pathol Lab Med; 1998 Dec; 122(12):1082-6. PubMed ID: 9870856
[TBL] [Abstract][Full Text] [Related]
11. Analyses of proliferative potential in schwannomas.
Abe M; Kawase T; Urano M; Mizoguchi Y; Kuroda M; Kasahara M; Suzuki H; Kanno T
Brain Tumor Pathol; 2000; 17(1):35-40. PubMed ID: 10982008
[TBL] [Abstract][Full Text] [Related]
12. Aberrant p53 expression in astrocytic neoplasms of the brain: association with proliferation.
Haapasalo H; Isola J; Sallinen P; Kalimo H; Helin H; Rantala I
Am J Pathol; 1993 May; 142(5):1347-51. PubMed ID: 7684193
[TBL] [Abstract][Full Text] [Related]
13. [Significance of p53 protein expression and proliferative potential with MIB-1 on tumor recurrence of pituitary adenomas].
Miyagami M; Nakamura S
No To Shinkei; 1998 Jan; 50(1):27-32. PubMed ID: 9493195
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of immunohistochemical expression of topoisomerase alpha II, MIB-1, p53, E-cadherin, retinoblastoma gene protein product, and HER-2/neu in adrenal and extra-adrenal pheochromocytomas.
Gupta D; Shidham V; Holden J; Layfield L
Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):267-74. PubMed ID: 11127918
[TBL] [Abstract][Full Text] [Related]
15. Desmoplastic infantile astrocytoma and ganglioglioma: a search for genomic characteristics.
Kros JM; Delwel EJ; de Jong TH; Tanghe HL; van Run PR; Vissers K; Alers JC
Acta Neuropathol; 2002 Aug; 104(2):144-8. PubMed ID: 12111357
[TBL] [Abstract][Full Text] [Related]
16. Value of topoisomerase II alpha, MIB-1, p53, E-cadherin, retinoblastoma gene protein product, and HER-2/neu immunohistochemical expression for the prediction of biologic behavior in adrenocortical neoplasms.
Gupta D; Shidham V; Holden J; Layfield L
Appl Immunohistochem Mol Morphol; 2001 Sep; 9(3):215-21. PubMed ID: 11556748
[TBL] [Abstract][Full Text] [Related]
17. Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas.
Jensen V; Sørensen FB; Bentzen SM; Ladekarl M; Nielsen OS; Keller J; Jensen OM
Histopathology; 1998 Jun; 32(6):536-46. PubMed ID: 9675593
[TBL] [Abstract][Full Text] [Related]
18. The significance of immunocytochemical markers, synaptophysin and neurofilaments in diagnosis of ganglioglioma.
Wierzba-Bobrowicz T; Schmidt-Sidor B; Gwiazda E; Bertrand E
Folia Neuropathol; 1999; 37(3):157-61. PubMed ID: 10581850
[TBL] [Abstract][Full Text] [Related]
19. Neuroblastomatous recurrence of ganglioglioma. Case report.
David KM; de Sanctis S; Lewis PD; Noury AM; Edwards JM
J Neurosurg; 2000 Oct; 93(4):698-700. PubMed ID: 11014552
[TBL] [Abstract][Full Text] [Related]
20. MIB-1 expression and iododeoxyuridine labelling in soft tissue sarcomas: an immunohistochemical study including correlations with p53, bcl-2 and histological characteristics.
Jensen V; Høyer M; Sørensen FB; Keller J; Jensen OM
Histopathology; 1996 May; 28(5):437-44. PubMed ID: 8735719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
